Matthew Webster

Matthew Webster has over 25 years of experience in specialty contracting, VBC, market access, LDDs, URAC, pharma formulary, and wholesale agreements. Matthew has held various roles in the healthcare industry, beginning in 2004 as the National Director, Product Line for Medco Health Solutions and AVP East at Accredo. In 2011, they became Vice President of Market Access and Reimbursement at Merz Pharma, followed by Vice President of Managed Care, Trade, and Distribution at Avita Drugs LLC in 2013. In 2015, they were the Managing Director at Webster Specialty Channel Management LLC, and then held the role of Vice President Managed Care at Matrix Health Group from 2016 to 2019. In 2016, they were Chief Operating Officer and Senior Vice President at Cooper Strategy, and then Director of IVC and Specialty Managed Care at Paragon Healthcare, Inc. in 2019. Most recently, they held the roles of Board Advisor, Payer Relations and Vice President, Payor Relations at SmileMD/OFFOR Health in 2021, and is currently Vice President, Market Access at Strata Oncology.

Matthew Webster has a comprehensive educational history. Matthew earned a BS in Business from Texas Wesleyan University between 1996 and 1998. Matthew then attended the Texas McCombs School of Business, where they obtained a Master of Business Administration - MBA in Health Management Pharmaceutical Economics and Marketing between 2001 and 2003. In 2012, they completed a RMC Certification from the Medical Management Institute in Registered Medical Coder. Finally, they earned an Executive MBA from Harvard University between 2010 and 2015. Webster also has a number of additional certifications, including Recognizing and Preventing Phishing Attacks from Traliant (2023), Anti-Bribery & Anti-Corruption V2 from Traliant (2022), Code of Conduct Essentials V3.21 from Traliant (2022), Data Privacy, General Data Protection Regulation & Information Security V2 from Traliant (2022), and Health Insurance Portability & Accountability Act for Texas Regulations (TMPA): Covered Entities V1.2 from Traliant (2022). Matthew is also a member of the American Cancer Society, National Hemophilia Foundation, American Society of Gene & Cell Therapy, American Academy of Neurology, and Pharmaceutical Care Management Association (PCMA). Matthew is also certified as an AMCP and Certified Medical Coder (CMC).